Effect of timing of vitamin B12 supplementation in patients receiving pemetrexed for treatment of advanced non-squamous non-small cell lung cancer or malignant pleural mesothelioma.

Zachary Schlei,Alison Meagher,Grace K. Dy,Karen Pfentner

Effect of timing of vitamin B12 supplementation in patients receiving pemetrexed for treatment of advanced non-squamous non-small cell lung cancer or malignant pleural mesothelioma.

2016

Zachary Schlei
Alison Meagher
Grace K. Dy
Karen Pfentner

e21682Background: Pemetrexed (Pem) is a folate analog inhibitor considered first line (1L) for advanced non-squamous non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma (MPM). Bef...

Keywords:

Pemetrexed
Mesothelioma
Vitamin B12
Squamous non-small cell lung cancer
Pathology
Oncology
Medicine
Internal medicine
first line
in patient
pleural mesothelioma
non small cell
non squamous
Lung cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations